CAS 56974-61-9 Pharmaceutical Raw Materials Gabexate Mesylate

Product Details
Customization: Available
Powder: Yes
Certification: ISO 9001, FDA
Still deciding? Get samples of US$ 45/gram
Request Sample
Diamond Member Since 2019

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
Experienced Team
The supplier has 12 foreign trading staff(s) and 10 staff(s) with over 6 years of overseas trading experience
In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
to see all verified strength labels (12)
  • CAS 56974-61-9 Pharmaceutical Raw Materials Gabexate Mesylate
  • CAS 56974-61-9 Pharmaceutical Raw Materials Gabexate Mesylate
  • CAS 56974-61-9 Pharmaceutical Raw Materials Gabexate Mesylate
  • CAS 56974-61-9 Pharmaceutical Raw Materials Gabexate Mesylate
  • CAS 56974-61-9 Pharmaceutical Raw Materials Gabexate Mesylate
  • CAS 56974-61-9 Pharmaceutical Raw Materials Gabexate Mesylate
Find Similar Products
  • Overview
  • Description
  • COA
  • Application & Funtion
  • Company
Overview

Basic Info.

Model NO.
SENTIAN-Pharmaceutical Raw Materials Gabexate Mesy
Use
Healthy
MOQ
10g
Transport Package
1kg/Bag, 25kg/Drum
Specification
99%
Trademark
SENTIAN
Origin
China
Production Capacity
5000 Kg Per Month

Product Description

.

 

Description

 

product name Gabexate Mesylate
CAS NO. 56974-61-9
Specification 99%
Appearance White powder
packing 1kg/bag,25kgs/drum
MOQ 1KG

Gabexate mesylate is a serine protease inhibitor used primarily to treat pancreatitis and disseminated intravascular coagulation. 

Biological activity and uses
Biological activity: Gabexate mesylate is a non-peptide protease inhibitor with an IC50 value of 0.19 μM for serine .

Uses: Mainly used to treat acute pancreatitis, acute attacks of chronic recurrent pancreatitis, acute pancreatitis complicated by surgery, frequent vascular thrombosis, etc..
In addition, it can also be used as a pharmaceutical intermediate

 

COA

 

Item Specification Test result
Appearance white powder Conforms
Assay 99% Conforms
Heavy metal ≤10ppm Conforms
Lead ≤2.0ppm Conforms
As ≤2.0ppm Conforms
Ca ≤1.0ppm Conforms
Me ≤0.1ppm Conforms
Total aerobic microbial count ≤1000CFU/g Conforms
Total moulds&yeast count ≤100CFU/g Conforms
Enterobacterial ≤10MPN/g Conforms
Salmonella N.D/25g Conforms
Escherichia coli N.D/10g Conforms
Staphylococcus aureus N.D/10g Conforms
Pseudomonas aeruginosa N.D/10g Conforms
Conclusion: Conform with specification.

 

Application & Funtion

Gabexate mesylate is only for intravenous drip, 100 mg each time, 300 mg daily for the first 3 days of treatment, and 100 mg/day after the symptoms are relieved, with a course of 6 to 10 days. First, inject 5 mL of water for injection into the bottle containing the lyophilized powder of gabexate, and transfer it into 500 ml of 5% glucose or Ringer's solution after it is dissolved for intravenous drip. The drip speed should not be too fast, and should be controlled within 1 mg/kg/h, and should not exceed 2.5 mg/kg/h.
 

Company

CAS 56974-61-9 Pharmaceutical Raw Materials Gabexate MesylateCAS 56974-61-9 Pharmaceutical Raw Materials Gabexate MesylateCAS 56974-61-9 Pharmaceutical Raw Materials Gabexate MesylateCAS 56974-61-9 Pharmaceutical Raw Materials Gabexate MesylateCAS 56974-61-9 Pharmaceutical Raw Materials Gabexate MesylateCAS 56974-61-9 Pharmaceutical Raw Materials Gabexate Mesylate

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier